NCT04866771View on ClinicalTrials.gov

Remotely Supervised tDCS for Slowing ALS Disease Progression

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

January 1, 2025

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
OTHER

Transcranial Direct Current Stimulation (tDCS)

Noninvasive brain stimulation

OTHER

Sham tDCS + anodal tDCS

Fake noninvasive brain stimulation or anodal noninvasive brain stimulation

Trial Locations (1)

60305

Brain Plasticity Lab, Chicago

All Listed Sponsors
collaborator

University of Chicago

OTHER

lead

University of Illinois at Chicago

OTHER

NCT04866771 - Remotely Supervised tDCS for Slowing ALS Disease Progression | Biotech Hunter | Biotech Hunter